experspadmin

Response to Immunotherapy in Black Men With mCRPC
Oncology

Response to Immunotherapy in Black Men With mCRPC

clinical study insights
By Daniel J. George, MD
The RTOG 9601 Experience: Amplifying the Clinical Benefit of Adjuvant Hormonal Therapy
Oncology

The RTOG 9601 Experience: Amplifying the Clinical Benefit of Adjuvant Hormonal Therapy

clinical study insights
By Neal D. Shore, MD, FACS
Immunotherapy Given Earlier in the Disease Course Improves Survival and Is Linked to Distinct Antibody Profiles
Oncology

Immunotherapy Given Earlier in the Disease Course Improves Survival and Is Linked to Distinct Antibody Profiles

clinical study insights
By William K. Oh, MD
Molecular Characterization of Oligometastatic Disease
Oncology

Molecular Characterization of Oligometastatic Disease

clinical study insights
By Guru P. Sonpavde, MD
Metastatic Consequences of Prostate Cancer: Initial Treatment
Oncology

Metastatic Consequences of Prostate Cancer: Initial Treatment

expert roundtables
By E. David Crawford, MD; Leonard Gomella, MD; Neal D. Shore, MD, FACS; Peter R. Carroll, MD, MPH
Load More